FDA Issues Guidance for Developers of Nicotine Replacement Drugs

Drug Industry Daily
A A
The FDA released draft guidance on drug development and trial design for nicotine replacement therapy (NRT) drugs.

To View This Article:

Login

Subscribe To Drug Industry Daily